See how your reported results read as versioned evidence records — linked to experiments and limitations.Know what the science actually supports before you trust the answer.
Press Enter ↵ to review claims
Explore by Goal
"We cannot solve our problems with the same thinking we used when we created them."
Based on the limited, explicitly provided evidence: the provided genome-wide LIM gene family work is computationally thorough and reproducible in its analytical pipeline, but it remains predictive-only (requires wet-lab validation), and the author’s broader publication set (as listed) includes retractions and many review/docking/in-silico style studies that can dilute causal biological inference. The overall scientific merit is therefore moderate-to-good, with major rigor uncertainty beyond the single detailed paper.
Epistemic scope constraint: Your prompt includes detailed raw information for one specific paper (LIM gene family in sorghum). For the rest of the author’s record, you provided mostly titles/metadata without method-level evidence from full text; therefore, my rigor critique is necessarily limited and should not be over-extended.
1) Evidence-backed “what’s strong” (from the explicitly provided paper details)
The provided sorghum LIM-family study is an in silico, genome-wide resource paper that reports gene identification, phylogeny, domain/motif verification, gene structure, chromosomal location, subcellular localization prediction, promoter CAREs, and predicted TF regulatory networks, using multiple established bioinformatics resources/tools.
2) Visuals from the provided LIM gene list (raw values you supplied)
These figures reflect only the numeric table excerpt you provided (SbLIM1–SbLIM5).
3) Scientific critique: what this paper does well vs what it cannot yet prove
Strengths (method breadth, internal coherence, and resource value)
Multi-source domain validation (Pfam/NCBI-CDD/SMART) reduces the odds that LIM-domain candidates are false positives.
Functional prediction scaffolding (GO terms, TF binding predictions, promoter cis-elements) is appropriate for a discovery/resource paper, as it maps plausible regulatory and functional contexts while clearly remaining hypothesis-generating.
Reproducibility posture: the study references commonly used computational pipelines and provides gene-level summarized features (e.g., accession numbers, exon/intron-derived structure, lengths, pI, GRAVY, localization predictions).
Limitations (core inability to establish causality)
No experimental validation: the study is explicitly computational (computational/in silico; no cell/animal models). Therefore, functional claims remain predictions, not demonstrated biological mechanisms.
Annotation & homology sensitivity: genome annotations and motif/domain detection can miss divergent LIM-like proteins or mis-annotate gene models, which would shift downstream phylogeny and structural inferences.
Cross-species extrapolation caution: the paper compares SbLIM architecture with Arabidopsis LIM patterns (as described in your excerpt), but even strong similarity does not guarantee identical biochemical roles across taxa.
4) Wider-author record: signal and uncertainty from your provided metadata
Your prompt lists numerous titles (including reviews and retraction notices) and provides bibliometric aggregates (OpenAlex and your internal citation metrics). However, because the prompt does not include full-text methods/data for most of those works, I cannot reliably infer the author’s wet-lab rigor, blinding practices, controls, or reproducibility beyond the one detailed LIM-paper.
Critical red-flags I can (and cannot) conclude
Retraction exists in the author’s listed works: you included a retraction notice entry titled “Retraction notice to ‘Stress-driven discovery in the natural products: A gateway towards new drugs’…” (retraction notice present as an item, but no details provided on why it was retracted). This is scientifically relevant because retractions can signal failures in validity, methodology, or integrity—yet, without the specific retraction rationale, I cannot map it to systematic issues vs isolated error. (No DOI/details were provided in your list for that retraction notice item.)
Dominance of review/in-silico motifs is plausible from titles (e.g., docking/DFT/network pharmacology/reviews), which can be valuable for hypothesis generation, but generally provides weaker evidence for causality than well-controlled experimental studies. Still, this is an inference from titles, not a validated assessment of methodological quality.
Bibliometric strength is high in the provided OpenAlex aggregate (works_count/cited_by_count/h_index are reported in your prompt). High citation counts can reflect genuine impact, but also can be inflated by review articles, broad-topic circulation, and citation network effects; therefore, citations alone cannot substitute for methodological rigor.
5) BGPT-style “known vs inferred vs uncertain” checklist
Known from provided evidence
The sorghum LIM study performs a multi-step computational gene-family identification and annotation workflow and explicitly contains computational/in silico scope only.
The paper reports predicted gene/protein features (lengths, pI, GRAVY, localization predictions, and regulatory/cis-element inferences).
Inferred (title/metadata only; lower confidence)
That the author may frequently work in computational/natural-products review spaces, which generally yields weaker mechanistic evidence than experimental validation. (This is based on the titles you provided, not on audited methods.)
The author’s typical experimental rigor (controls, randomization/blinding, replication) across the broader publication set.
The exact reason(s) behind any retracted items you listed.
6) Practical next step for you (BGPT workflow)
If you want a truly rigorous author audit, the highest-information approach is to fetch and inspect a representative sample of the author’s experimental papers and retracted items for: study design, controls, statistical reporting, and whether data are available.
7) Bottom-line judgment (with confidence)
Best-supported conclusion: From the provided detailed LIM-family paper, Abdur Rauf’s computational contribution appears methodologically broad and plausibly reproducible, but it does not establish biological causality because it is explicitly computational/in silico.
Overall author scoring confidence:low-to-moderate, because I only have deep evidence for one paper; the rest is title/metadata without method-level auditing.
It will parse the provided SbLIM gene feature table, compute summary stats (pI, length, GRAVY), generate Plotly bar charts for each feature, and output a sortable table for quick comparison.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
“All SbLIMs perform the same core cellular function across sorghum.” Rejected by the provided protein-feature outlier behavior (especially SbLIM5) and by the general principle that sequence/architecture divergence often correlates with functional divergence.
“GO/TF/promoter predictions are sufficient evidence of in vivo regulation.” Rejected because the study is explicitly computational and lacks experimental validation, making these claims inherently hypothesis-level.
Science Art
Science Movie
Make a narrated HD Science movie for this answer ($32 per minute)
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Analysis 
Hypothesis Graveyard
Discussion